Tango Therapeutics · 1 month ago
Senior Director, Medical Affairs
Boston, MA
Full-time
Onsite
Director/Executive
10+ years expTango Therapeutics is a biotechnology company dedicated to discovering novel drug targets for precision medicine in cancer treatment. They are seeking a Senior Director of Medical Affairs to oversee Medical Affairs execution, manage a global MSL team, and ensure alignment with clinical development priorities while supporting late-stage development and commercialization efforts.
BiotechnologyHealth CareMedicalTherapeutics
Responsibilities
Manage MSL vendor(s), defining scope, coverage, and performance expectations
Provides strategic and operational leadership to a global MSL team, fostering alignment, collaboration, and high-quality scientific exchange across diverse regions and healthcare systems
Provide scientific training through quarterly sessions and ongoing data updates
Monitor MSL activities, KOL engagement quality, and field insights; translate findings into strategic recommendations
Direct MSL priorities for investigator education and enrollment acceleration at underperforming sites
Map priority KOLs by region with specific engagement objectives for MSL execution
Manage advisory boards to gather insights and validate strategy
Develop publication plans with journal targets, authors, and timelines
Create compliant medical education materials (slide decks, data summaries, FAQs) for MSL field use
Represent Tango at 4-6 major congresses annually
Build patient advocacy function through partner identification and engagement planning
Partner with Clinical Operations on site strategy and investigator support
Comfortable with frequent travel to build strong relationships with KOLs and actively participate in scientific meetings and major industry conferences
Qualification
Required
MD, PhD, or equivalent advanced scientific degree
Minimum of 10 years of experience in Medical Affairs within biotech/pharma
Deep expertise in oncology and strong experience in late-stage clinical development and product launch preparation
Experience in building and leading high-performing Medical Affairs teams, including MSLs and vendor management
Knowledge of applicable global regulatory and compliance frameworks (FDA, EMA, GCP, ICH)
Strong network of Oncology KOLs, health authorities, and scientific organizations, and demonstrated success in engaging these stakeholders
Ability to travel regularly to our Boston headquarters
Company
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
51-200 employees
Funding
Current Stage
Public CompanyTotal Funding
$548MKey Investors
Nextech InvestBoxer CapitalCasdin Capital
2025-10-23Post Ipo Equity· $197M
2021-08-11Post Ipo Equity· $186M
2021-08-11IPO
Leadership Team
Barbara Weber
President and CEO
Jannik N. Andersen
Chief Scientific Officer
Recent News
2026-01-11
2026-01-09
Company data provided by crunchbase